Search results

130 items matching your search terms.
Filter the results.
Item type













New items since



Sort by relevance · date (newest first) · alphabetically
Excess weight impacts the health of NC women
UNC report card finds more women are overweight than not
Located in Vital Signs / 2014 / May 15
FDA Approves ZULRESSO™ (brexanolone) Injection for Postpartum Depression Following Three Clinical Trials Led by UNC Researcher
ZULRESSO, developed by Sage Therapeutics, is the first and only treatment specifically indicated to treat postpartum depression in women. UNC School of Medicine’s Samantha Meltzer-Brody, MD, MPH, was the principal investigator for three clinical trials showing rapid-reduction in depressive symptoms, and says the approval marks a major step forward in women’s healthcare.
Located in News / 2019 / March
Funds Available in the UNC Lymphedema Program
Thanks to the generosity of Susan G. Komen for the Cure, eligible breast cancer patients who develop lymphedema may apply for funds awarded to the Department of Physical Medicine & Rehabilitation to provide them with compression garments and wraps critical to their therapeutic intervention.
Located in Vital Signs / 2009 / Vital Signs - Dec. 10, 2009
Funds Available in the UNC Lymphedema Program
Thanks to the generosity of Susan G. Komen for the Cure, eligible breast cancer patients who develop lymphedema may apply for funds awarded to the Department of Physical Medicine & Rehabilitation to provide them with compression garments and wraps critical to their therapeutic intervention.
Located in Vital Signs / Archives / Vital Signs - Dec. 10, 2009
Horizons progam assists women in need
Recently featured in the Chapel Hill News, Horizons helps women with addictions to learn the skills they need to rebuild their lives.
Located in Vital Signs / 2008 / October
Hormone therapy could effectively prevent depression for some women in the menopause transition
Research conducted by Susan Girdler, PhD, and David Rubinow, MD, and published in JAMA Psychiatry, is the first to conclude that a year of hormone therapy can effectively prevent the onset of depressive symptoms for women during the menopause transition.
Located in News / 2018 / January
Introducing our new M.O.M. (mentoring other mothers) networking group
This fun and social networking group is designed for pre- and postnatal moms and their babies (ages newborn to 5 and a half months), and meets each Tuesday morning and/or Thursday evening.
Located in Employee News Online / 2011 / June 15
Investigational Treatment for Postpartum Depression Consistently Reduced Symptoms Across Three Trials, Supporting Submission for FDA Approval
The findings of the integrated analysis from one phase 2 and two phase 3 pivotal trials were published today in The Lancet. Lead author Samantha Meltzer-Brody, MD, MPH, of the UNC School of Medicine said the promising results mark a major step forward in women’s health care.
Located in News / 2018 / August
John M. Thorp, Jr., MD
John M. Thorp, Jr., MD is Professor and Director of Women's Primary Healthcare in the Department of Obstetrics and Gynecology. He is an expert on preterm birth, cervical insufficiency, clinical trials, nutrition in pregnancy, health disparities, alcohol and drug abuse research, and outreach education.
Located in For the Media / Experts Guide
Largest studies of robotic-assisted surgery for gynecologic procedures find fewer complications
Since 2000, hundreds of hospitals worldwide have used robotic surgical systems to equip surgeons with enhanced vision and dexterity when performing minimally invasive procedures.
Located in Vital Signs / 2008 / November